Patent details
EP3320911 Title: ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS
Basic Information
- Publication number:
- EP3320911
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP171828700
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS
- French Title of Invention:
- ANTAGONISTES DE L'ACTIVINE-ACTRII ET SES UTILISATIONS POUR ACRROITRE LES NIVEAUX DE GLOBULES ROUGES
- German Title of Invention:
- AKTIVIN-ACTRII-ANTAGONISTEN UND IHRE VERWENDUNGEN ZUR ERHÖHUNG DER ERYTHROZYTENSPIEGEL
- SPC Number:
Dates
- Filing date:
- 18/12/2007
- Grant date:
- 01/12/2021
- EP Publication Date:
- 16/05/2018
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/12/2021
- EP B1 Publication Date:
- 01/12/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 18/12/2021
- Expiration date:
- 18/12/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/11/2021
- Name:
- Acceleron Pharma Inc.
- Address:
- 128 Sidney Street, Cambridge, MA 02139, United States (US)
Inventor
- Name:
- SHERMAN, Matthew L.
- Address:
- United States (US)
Priority
- Priority Number:
- 875682 P
- Priority Date:
- 18/12/2006
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 38/17; C12N 15/62; A61P 7/06; C07K 14/41;
Publication
European Patent Bulletin
- Issue number:
- 202148
- Publication date:
- 01/12/2021
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|